Loading company
$9.23-1.5%Nov 13 close
Figures through June 30, 2026, from the 6-K filed August 20, 2026
Past performance
- 1W
- -4.2%
- 1M
- -12.7%
- 3M
- -21.9%
- 6M
- -12.6%
- 1Y
- -1.2%
$9.23-1.5%Nov 13 close
Figures through June 30, 2026, from the 6-K filed August 20, 2026
From the company’s own 6-K filing.
Telix Pharmaceuticals Ltd has no earnings call transcript available.
The quote and the company description come from the 6-K Telix Pharmaceuticals Ltd filed on August 20, 2026 with its results; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.